These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3590069)

  • 1. [Monitoring adverse drug effects in Spain].
    Laporte JR
    Therapie; 1987; 42(1):63-4. PubMed ID: 3590069
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monitoring adverse drug effects in Czechoslovakia].
    Fousková H
    Cesk Farm; 1988 Oct; 37(8):344-5. PubMed ID: 3208301
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug by drug imputation of adverse effects in drug monitoring. Attempted comparison of different methods].
    Lagier G; Vincens M; Lefebure B; Frelon JH
    Therapie; 1983; 38(3):295-302. PubMed ID: 6612666
    [No Abstract]   [Full Text] [Related]  

  • 4. The Welsh Adverse Drug Reactions Scheme: experience of a UK regional monitoring centre.
    Houghton JE; Pinto Pereira LM; Woods FJ; Richens A; Routledge PA
    Adverse Drug React Toxicol Rev; 1996 Jun; 15(2):93-107. PubMed ID: 8836315
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adverse effects and drug interactions].
    Perlík F
    Cas Lek Cesk; 2004; 143(2):110-3. PubMed ID: 15077574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring for adverse drug events.
    Kennedy DL; Goldman SA
    Am Fam Physician; 1997 Nov; 56(7):1718, 1721. PubMed ID: 9371003
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adverse drug reactions in the Spanish medical bibliographic literature: a comparison of 3 periods].
    López-Oliva AG; Vargas Castrillón E; García Mateos M; García Arenillas M; Terleira Fernández A; Moreno González A
    Med Clin (Barc); 1999 Jan; 112(2):55-6. PubMed ID: 10065430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adverse effects of drugs in old people. Evaluation of cases received for a year at the French Association of Drug Monitoring Centers].
    Lavarenne J; Dumas R; Cayrol C
    Therapie; 1983; 38(5):485-93. PubMed ID: 6670071
    [No Abstract]   [Full Text] [Related]  

  • 9. [A literature review of adverse drug reaction reports. Adverse drug effects can have genetical background].
    Rane A
    Lakartidningen; 2002 May; 99(20):2266-7. PubMed ID: 12082942
    [No Abstract]   [Full Text] [Related]  

  • 10. [Assessment of the severity and cost of adverse drug effects recorded at the Paris-Fernand Widal Drug Monitoring Center during 2 monthly periods].
    Castot A; Lagier G; Merigot P; de Crémoux P; Efthymiou ML
    Therapie; 1987; 42(4):365-7. PubMed ID: 3686469
    [No Abstract]   [Full Text] [Related]  

  • 11. [Methods of adverse drug reactions monitoring. II. Frequencies estimations (author's transl)].
    Spriet-Pourra C; Spriet A; Soubrie C; Simon P
    Therapie; 1982; 37(1):13-22. PubMed ID: 7089914
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fatal drug adverse effects].
    Reseland S
    Tidsskr Nor Laegeforen; 2005 Mar; 125(6):786. PubMed ID: 15776090
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure to recognize adverse drug reactions despite warnings.
    Griffin JP
    Adverse Drug React Toxicol Rev; 1999 Mar; 18(1):1-3. PubMed ID: 10401518
    [No Abstract]   [Full Text] [Related]  

  • 14. [Classification and profile of adverse drug effects].
    Cordonnier M
    Bull Soc Belge Ophtalmol; 2007; (304):15-6. PubMed ID: 17718223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions--when is an adverse drug reaction not an adverse drug reaction?
    Leber P
    Psychopharmacol Bull; 1982 Apr; 18(2):6-9. PubMed ID: 7051080
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug-eruptions].
    Thielen AM; Toutous-Trellu L; Desmeules J
    Rev Med Suisse; 2008 Jul; 4(165):1671-5. PubMed ID: 18767294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Most adverse drug events unreported: take these steps.
    Hosp Peer Rev; 2007 Oct; 32(10):143-5. PubMed ID: 17957885
    [No Abstract]   [Full Text] [Related]  

  • 18. [Critical analysis of the adverse effects reported to the Paris-Fernand Widal Drug Monitoring Center in a 2-month period].
    Castot A; Carlier P; Lagier G; Elmalem J; Vincens M; Efthymiou M
    Therapie; 1986; 41(5):375-7. PubMed ID: 3810528
    [No Abstract]   [Full Text] [Related]  

  • 19. [The Spanish drug surveillance system].
    Laporte JR; Capellà D
    Med Clin (Barc); 1994 Sep; 103(9):335-6. PubMed ID: 7967892
    [No Abstract]   [Full Text] [Related]  

  • 20. [Increased significance of adverse effects of drugs--a threat to the industry].
    Werkö L
    Lakartidningen; 2004 Dec; 101(50):4134-6. PubMed ID: 15631270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.